Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01

Table 2

Treatment responses ().

		%	median (m/m)
Complete remission	273	90.4
Failure	8	2.6
Early death	21	7.0
Treatment dropout	6	2.0
Relapse
No	223	73.8
Yes	79	26.2
Time of relapse
Very early	27	8.9
Early	40	13.2
Late	12	4.0
Site of relapse
Bone marrow (BM)	55	18.2
NCS	8	2.6
BM + NCS	13	4.3
Testicle	3	1.0
Dead	193	63.9
Alive	109	36.1
Duration of follow-up (years)			3.9 (7 days–7.3)

m/m: minimum/maximum.